Inventaire - your friends and communities are your best library - Inventaire

Cellular immunotherapy for malignant gliomas

published in: Expert Opinion on Biological Therapy

date of publication: 2016-07-19

language: English

main subject: immunotherapy

Cites articles 118

Date

Title

Authors

2016-04-01

Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy

Carl H. June
2016-02-12

Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma

Matthias Piesche, Patrick Y Wen, Alexandra Golby
2016-01-27

Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
2015

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

Rayne H Rouce
2015-11

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

Christel Herold-Mende, Enrico Franceschi, Robert M. Prins, Michael Weller, Wolfgang Wick, David A Reardon, Patrick Y Wen, Raymond Y Huang, Whitney Pope, John Sampson, Gaetano Finocchiaro, Hideho Okada, Alba A. Brandes, Benjamin M Ellingson, Ian F Pollack, Lakshmi Nayak, Ashok Panigrahy
2015-11-01

Vaccination strategies for neuro-oncology

John Sampson
2015-10-27

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

Quinn T Ostrom, Jill S. Barnholtz-Sloan
2015-07-27

Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report

Patrick Hwu, Chantale Bernatchez, Orenthial J Fulbright, Michael A Davies, Scott E Woodman, Isabella C Glitza, Cara Haymaker, Renjith Ramachandran, Christopher A Toth, Rahmatu Mansaray, Seth Wardell, Wen-Jen Hwu, Luis Vence, Michelle M Rohlfing
2015-07-20

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

Dan T Vogl, Alfred L Garfall, Carl H. June, Bruce L. Levine, Simon F Lacey, Edward A. Stadtmauer, Sandra Westphal, Saul Yanovich, Sunita Philip, Gwendolyn K Binder-Scholl, Ashraf Z Badros, Brendan M Weiss, Jeffrey Finklestein, Irina Kulikovskaya, Minnal Gupta, Nicholas J Pumphrey, Helen K Tayton-Martin, Lilliam Ribeiro, Naseem D S Kerr, Michael Kalos
2015-05-08

Seatbelts in CAR therapy: How Safe Are CARS?
2015-06-09

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

Christine E Brown
2015-05-18

TRUCKs: the fourth generation of CARs
2015-04-01

Adoptive cell transfer as personalized immunotherapy for human cancer

Nicholas P. Restifo, Steven Rosenberg
2015-03-11

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

April Coan, Henry Seth Friedman, Darell D. Bigner, Annick Desjardins, Allan Friedman, David A Reardon, Roger E McLendon, James J Vredenburgh, James H. Herndon, Kendra L Congdon, Smita K Nair, Duane A Mitchell, Kristen A Batich
2015-03-01

Nivolumab in NSCLC: latest evidence and clinical potential

Raghav Sundar, Byoung Chul Cho
2015-02-01

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma

Shannon E McGettigan, Alexandria P. Cogdill, Hideho Okada, Carl H. June, Avery D. Posey
2015-02-13

The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation

Lawrence S Lamb, Shun Wong
2015-01-22

Nivolumab in previously untreated melanoma without BRAF mutation

Georgina V. Long, Michele Maio, Piotr Rutkowski, Ewa Kalinka-Warzocha, Julie Charles, Vanna Chiarion Sileni, Ana Arance, Paolo Antonio Ascierto
2014-12-23

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

Nicholas P. Restifo, Steven Rosenberg, Chyi-Chia R Lee, John R Wunderlich, Udai S Kammula, Marybeth S Hughes, Mark Raffeld, Steven R. Feldman, Sadik H Kassim
2014-11-25

Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC

Lisa H. Butterfield, Gary Kohanbash, Hideho Okada
2014-10-16

Chimeric antigen receptor T cells for sustained remissions in leukemia

Yolanda Mahnke, David T Teachey, Carl H. June, David L. Porter, Bruce L. Levine, Stephan A Grupp, Simon F Lacey, Noelle V. Frey, Shannon L Maude, Richard Aplenc, Nancy J Bunin, Sue Anne Chew, Vanessa Gonzalez-Covarrubias, Jan Melenhorst, Susan R Rheingold
2014-09-04

Immunotherapy advances for glioblastoma

John Sampson, Patrick Y Wen, Gordon J. Freeman
2014-07-15

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Richard F. Kefford, Jeffrey S Weber, Anthony M Joshua, Richard W. Joseph, Bartosz Chmielowski, Adil Daud, Jedd D Wolchok, Antoni Ribas, F Stephen Hodi, Roxana S. Dronca, Tara C Gangadhar
2014-07-04

Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
2014-06-02

Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem

Lisa H. Butterfield, Hideho Okada
2014-05-15

Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies

Dean A. Lee, Robert C. Bast, M Helen Huls, Richard E Champlin
2014-06-25

A vaccine targeting mutant IDH1 induces antitumour immunity.

Felix Sahm, Angelika B. Riemer, Uğur Şahin, Manuel A. Friese, Michael Platten, Lukas Bunse, Stefan Pusch, Stefan Eichmüller, Wolfgang Wick, Andreas von Deimling, Stefan Stevanović, Matthias Osswald, Theresa Schumacher, Iris Oezen, Katharina J Rauschenbach, Martina Ott, Jürgen G Okun, Philipp Beckhove
2013-12-16

Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts

Carl H. June, Atsushi Natsume
2013-10-10

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy

Michael H. Kershaw, Phillip K. Darcy, Liza B John
2013-12-12

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
2013-08-13

Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma

Fatima A Merchant, Helen Heslop
2013-08-01

Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells

James L. Riley, Carl H. June, Bruce L. Levine, Edward A. Stadtmauer, Gwendolyn K Binder-Scholl, Irina Kulikovskaya, Minnal Gupta, Nicholas J Pumphrey, Michael Kalos, Gerald P Linette, Namir J Hassan, Gabriela Plesa

Article - wd:Q38902169

Welcome to Inventaire

the library of your friends and communities

you are offline